DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Autoimmune IVD Testing Market" report to their offering. This report provides important business planning information ...
Increase in prevalence of autoimmune diseases, rise in technological advancements, and rise in awareness about early diagnosis are the major factors which drive the global market growth. Increasing ...
Autoimmune diseases often present with overlapping, non-specific symptoms that complicate timely diagnosis and treatment. This complexity is magnified for individuals with polyautoimmunity, ...
Exagen Inc. has reached a major milestone by completing its 1,000,000th AVISE CTD test, a diagnostic tool for autoimmune and connective tissue diseases. This achievement highlights the company’s ...
In this video, Jonathan A. Bernstein, MD, discusses an American College of Allergy, Asthma & Immunology Annual Scientific ...
SAN DIEGO, July 24, 2012 /PRNewswire/ -- Genalyte, Inc., a life sciences company developing and commercializing innovative next generation multiplexing technology, today announced availability of the ...
The MosaiQ solution is a next-generation IVD solution for autoimmune diseases, allergies and beyond. The multiplexed, fully automated planar microarray platform enables syndromic testing for complex ...
A research team from the University of Oklahoma Health Sciences Center, led by Madeleine Cunningham, Ph.D., in conjunction with the National Institute of Mental Health (NIMH), has developed the ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire select operating assets and ...
Autoimmune diseases are on the rise. It’s not just a hunch—autoimmune diseases are rising sharply, and the numbers are too significant to ignore. These chronic conditions, where the immune system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback